作者
Tadateru Takayama,Takafumi Hiro,Masakazu Yamagishi,Hiroyuki Daida,Atsushi Hirayama,Satoshi Saito,Tetsu Yamaguchi,Masunori Matsuzaki,The COSMOS Investigators
出处
期刊:Circulation journal
[Japanese Circulation Society]
日期:2009-01-01
卷期号:73 (11): 2110-2117
被引量:211
标识
DOI:10.1253/circj.cj-09-0358
摘要
BACKGROUND: It has been suggested that intensive lipid-lowering therapy using statins significantly decreases atheromatous plaque volume. The effect of rosuvastatin on plaque volume in patients with stable coronary artery disease (CAD), including those receiving prior lipid-lowering therapy, was examined in the present study. METHODS AND RESULTS: A 76-week open-label trial was performed at 37 centers in Japan. Eligible patients began treatment with rosuvastatin 2.5 mg/day, which could be increased at 4-week intervals to
科研通智能强力驱动
Strongly Powered by AbleSci AI